Phibro Animal Health (NASDAQ:PAHC) Stock Rating Cut to "Hold" at Wall Street Zen

Phibro Animal Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report issued on Saturday, Wall Street Zen reports.

A number of other equities analysts have also weighed in on PAHC. Weiss Ratings lowered Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday. Zacks Research cut Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, November 10th. Three analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $46.50.

View Our Latest Research Report on PAHC

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $33.29 on Friday. The company has a market capitalization of $1.35 billion, a PE ratio of 13.26 and a beta of 0.42. Phibro Animal Health has a twelve month low of $28.25 and a twelve month high of $60.08. The company has a quick ratio of 1.28, a current ratio of 3.20 and a debt-to-equity ratio of 1.70. The stock's 50 day moving average price is $36.51 and its 200-day moving average price is $40.75.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.78 by $0.01. The business had revenue of $386.77 million during the quarter, compared to the consensus estimate of $382.42 million. Phibro Animal Health had a net margin of 6.66% and a return on equity of 35.88%. On average, equities analysts anticipate that Phibro Animal Health will post 3.48 EPS for the current year.

Institutional Trading of Phibro Animal Health

Hedge funds have recently made changes to their positions in the business. KBC Group NV purchased a new position in Phibro Animal Health during the 1st quarter valued at $29,000. Sterling Capital Management LLC increased its holdings in Phibro Animal Health by 864.9% in the 3rd quarter. Sterling Capital Management LLC now owns 714 shares of the company's stock worth $26,000 after buying an additional 640 shares during the period. Quarry LP boosted its holdings in Phibro Animal Health by 570.8% in the third quarter. Quarry LP now owns 758 shares of the company's stock valued at $27,000 after purchasing an additional 645 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Phibro Animal Health in the third quarter worth about $39,000. Finally, Hughes Financial Services LLC lifted its holdings in Phibro Animal Health by 93.4% during the third quarter. Hughes Financial Services LLC now owns 1,659 shares of the company's stock valued at $64,000 after purchasing an additional 801 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation develops and markets products for animal health and nutrition. Its portfolio includes vaccines, medicated feed additives, and nutritional specialty products designed to support the health and productivity of livestock and other animals. The company also supplies trace minerals and related products used in animal nutrition and other applications. Its products serve markets including poultry, cattle, swine, and aquaculture, and are sold to customers in the United States and internationally.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Phibro Animal Health Right Now?

Before you consider Phibro Animal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.

While Phibro Animal Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines